Evidence map›Paper›PMID 28054352›Full record

ArticleClinical and experimental immunology2017

Impact of interleukin 13 (IL13) genetic polymorphism Arg130Gln on total serum immunoglobulin (IgE) levels and interferon (IFN)-γ gene expression.

B Smolkova, J Tulinska, L Palkovicova Murinova, V Buocikova, A Liskova, K Rausova, M Kuricova, H Patayova, M Sustrova, E Neubauerova Svorcova and 7 more

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Gene polymorphisms in asthma: a narrative review.Annals of translational medicine · 2022
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

B SmolkovaCancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.ORCID 0000-0002-4906-5652
J TulinskaFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
L Palkovicova MurinovaFaculty of Public Health, Slovak Medical University, Bratislava, Slovakia.
V BuocikovaFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
A LiskovaFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
K RausovaFaculty of Public Health, Slovak Medical University, Bratislava, Slovakia.
M KuricovaFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
H PatayovaFaculty of Public Health, Slovak Medical University, Bratislava, Slovakia.
M SustrovaFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
E Neubauerova SvorcovaFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
S IlavskaFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
M SzabovaFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
T NemessanyiFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
E JahnovaFaculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
M DusinskaHealth Effects Laboratory, Department of Environmental Chemistry, NILU-Norwegian Institute for Air Research, Kjeller, Norway.
P CiznarFaculty of Medicine, 1st Pediatric Department, Comenius University, Bratislava, Slovakia.
L FuortesCollege of Public Health, University of Iowa, Iowa City, IA, USA.
Slovak Medical University · SKComenius University Bratislava · SKNILU · NOUniversity of Iowa · US

Funding

Iowa Int'l Research &Training in Environ &Occup HealthD43TW000621 · FIC · UNIVERSITY OF IOWA · PI COOK, THOMAS M · 1995 to 2011
$2.8M
FIC NIH HHS D43 TW000621
6 · The paper itself

Abstract

This cross-sectional study was designed to investigate the extent of genetic susceptibility by targeting variants in interleukin (IL)-4/IL-13 signalling pathways leading to atopic disease in early childhood. We evaluated involvement of five single nucleotide polymorphisms IL4 C-590T, IL13 C-1055T, IL13 Arg130Gln, IL4RA Ile50Val and IL4RA Gln576Arg, in the control of serum total and antigen-specific immunoglobulin (Ig)E levels. Furthermore, we analysed their association with changes in gene expression of five cytokines having key roles in inflammatory and anti-inflammatory immune response [IL-4, IL-13, interferon (IFN)-γ, IL-8 and IL-10]. Total and antigen-specific IgE levels in serum and gene expression of selected cytokines in peripheral blood were measured in 386 children aged 1-8 years. TaqMan allelic discrimination, amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) and restriction fragment length polymorphisms (RFLP) methods validated by sequencing were used for genotyping. All genotypes for children with total and antigen-specific IgE levels in the normal range were in Hardy-Weinberg equilibrium. Gene expression analyses were carried out using TaqMan gene expression assays. We found elevated total IgE levels in carriers of IL13 Arg130Gln variant allele [odds ratio (OR) = 1·84; 95% confidence interval (CI) = 1·16-2·93]. This effect was more apparent for boys (OR = 2·31; 95% CI = 1·25-4·28). However, no significant association was observed for the other four variants examined. We found up-regulation of IFN-γ in children with elevated serum total IgE levels carrying the Arg130 allele (P = 0·005). No differences were found for IL4, IL8 or IL10, while IL13 gene expression was under the detection limit. IL13 Arg130Gln genotypes can play a role in genetic susceptibility to allergy via regulation of serum total IgE levels and affecting IFN-γ gene expression.

Indexed as

Amino Acid SubstitutionCodonGene ExpressionPolymorphism, Single NucleotideAllelesChildChild, PreschoolCross-Sectional StudiesFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansHypersensitivityImmunoglobulin ECodonImmunoglobulin EInterferon-gammaInterleukin-13Receptors, Interleukin-4allergycytokinesmolecular biology

Identifiers

PMID28054352
PMCPMC5343340
OpenAlexW2623368734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.